BioCentury
ARTICLE | Clinical News

SymlinPen regulatory update

October 22, 2007 7:00 AM UTC

FDA approved an sNDA from AMLN for the SymlinPen 120 and SymlinPen 60 pen-injector devices for administration of Symlin pramlintide. The synthetic amylin analog is approved for use in conjunction wit...